A complex comprising a Cyclodextrin inclusion),(b) and (c) a fulvestrant Carrier; Preparation method; Formulation and dosage form comprising the complex; Preparation that comprises the complex or the formulation and its use in the treatment;Asbestos Cancer and lupus erythematosus, among other diseases.
Provided are inclusion complexes comprising fulvestrant and a cyclodextrin. The complexes may be useful for treating various conditions, such as cancer and systemic lupus crythematosus. Also provided are methods of producing the inclusion complexes, methods of using the inclusion complexes in therapy, and kits and unit dosages comprising the complexes.UN COMPLEJO DE INCLUSION QUE COMPRENDE UN COMPUESTO DE FORMULA (I) (FULVESTRANT) Y UNA CICLODEXTRINA; FORMULACION FARMACEUTICA QUE LO COMPRENDE, UNA PREPARACION; UN METODO DE PRODUCCCION DEL COMPLEJO DE INCLUSION; UN METODO PARA MEJORAR LA SOLUBILIDAD DEL COMPUESTO DE FORMULA (I); USO DEL COMPLEJO DE INCLUSION PARA TRATAR CANCER.